KLBF.JK

PT Kalbe Farma Tbk. [KLBF.JK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

KLBF.JK Stock Summary

Top 10 Correlated ETFs

KLBF.JK


Top 10 Correlated Stocks

KLBF.JK


In the News

KLBF.JK Financial details

Company Rating
Buy
Market Cap
73777.68B
Income
2961.62B
Revenue
30312.74B
Book val./share
-
Cash/share
-
Dividend
38
Dividend %
2.37%
Employees
13.17K
Optionable
No
Shortable
Yes
Earnings
31 Oct 2023
P/E
25.21
Forward P/E
18.85
PEG
-10.83
P/S
2.45
P/B
3.61
P/C
-
P/FCF
34.72
Quick Ratio
2.17
Current Ratio
3.9
Debt / Equity
0.05
LT Debt / Equity
0.01
-
-
EPS (TTM)
52.11
EPS next Y
84.9
EPS next Q
-
EPS this Y
7.05%
EPS next Y
62.92%
EPS next 5Y
76.29%
EPS last 5Y
6.76%
Revenue last 5Y
6.54%
Revenue Q/Q
0.99%
EPS Q/Q
-
-
-
-
-
SMA20
-5.79%
SMA50
-9.51%
SMA100
-19.76%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
14%
ROC
0.17%
Gross Margin
39%
Oper. Margin
13%
Profit Margin
10%
Payout
-
Shs Outstand
46.26B
Shs Float
18.96B
-
-
-
-
Target Price
-
52W Range
1550.0-2360.0
52W High
-32.2%
52W Low
+3.23%
RSI
41.05
Rel Volume
0.35
Avg Volume
29.55M
Volume
10.28M
Perf Week
-1.54%
Perf Month
-11.36%
Perf Quarter
-21.57%
Perf Half Y
-24.17%
-
-
-
-
Beta
0.251
-
-
Volatility
18.65%, 72.05%
Prev Close
-0.31%
Price
1600
Change
-1.54%

KLBF.JK Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
449.58482.85493.07560.26622.01
Net income per share
52.4253.4858.3167.9272.71
Operating cash flow per share
59.1153.489.9260.2981.04
Free cash flow per share
29.8211.0966.0638.9462.33
Cash per share
71.0869.04115.12138.1488.04
Book value per share
311.97339.05371.32417.71438.24
Tangible book value per share
316.38341.61375.09428.99442.2
Share holders equity per share
311.97339.05371.32417.71438.24
Interest debt per share
8.0418.0926.3214.3325.99
Market cap
71250.19B75937.7B69374.46B75699.81B97218.32B
Enterprise value
68454.27B73714.06B65324.34B70109.72B94436.26B
P/E ratio
2930.2925.3823.7828.74
Price to sales ratio
3.383.3632.883.36
POCF ratio
25.7130.3416.4626.7925.79
PFCF ratio
50.98146.0222.441.4833.53
P/B Ratio
4.874.783.993.874.77
PTB ratio
4.874.783.993.874.77
EV to sales
3.253.262.832.673.26
Enterprise value over EBITDA
18.4119.9916.4315.5519.35
EV to operating cash flow
24.7129.4515.524.8125.05
EV to free cash flow
48.97141.7521.138.4132.57
Earnings yield
0.030.030.040.040.03
Free cash flow yield
0.020.010.040.020.03
Debt to equity
0.020.050.070.030.06
Debt to assets
0.020.040.050.020.04
Net debt to EBITDA
-0.75-0.6-1.02-1.24-0.57
Current ratio
4.664.354.124.453.77
Interest coverage
167.49110.0447.9691.47108.97
Income quality
1.130001.11
Dividend Yield
0.020.020.020.020.02
Payout ratio
0.480.490.450.410.48
Sales general and administrative to revenue
0.020.020.020.020.02
Research and developement to revenue
0.020.020.020.020.01
Intangibles to total assets
0.030.030.030.050.06
Capex to operating cash flow
-0.5-0.79-0.27-0.35-0.23
Capex to revenue
-0.07-0.09-0.05-0.04-0.03
Capex to depreciation
0000-2.25
Stock based compensation to revenue
00000
Graham number
606.58638.72697.97798.97846.73
ROIC
0.170.150.150.160.16
Return on tangible assets
0.140.130.120.130.13
Graham Net
107.99100.07126.53164.19141.98
Working capital
8362.12B8645.38B9898.61B12177.55B12279.19B
Tangible asset value
14830.29B16013.13B17582.23B20108.07B20569.21B
Net current asset value
7796.68B7663.35B8787.11B11311.45B11566.24B
Invested capital
0.020.050.070.030.06
Average receivables
3623.27B3992.93B4112.01B4067.41B4811.75B
Average payables
1199.22B1252.88B1228.12B1453.99B1832.11B
Average inventory
3516.04B3606.28B3668.86B4343.52B6057.33B
Days sales outstanding
65.6967.6263.6557.0469.63
Days payables outstanding
41.9435.8235.1940.6442.3
Days of inventory on hand
112.97110.12102.12123.98148.87
Receivables turnover
5.565.45.736.45.24
Payables turnover
8.710.1910.378.988.63
Inventory turnover
3.233.313.572.942.45
ROE
0.170.160.160.160.17
Capex per share
-29.29-42.3-23.86-21.35-18.71

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
313.59K166.65169.17157.150
Net income per share
36.42K19.2818.414.470
Operating cash flow per share
40.29K21.918.47.230
Free cash flow per share
28.77K16.5114.261.080
Cash per share
185.05K88.0477.9662.130
Book value per share
835.58K438.24455.77432.310
Tangible book value per share
855.83K442.2459.79432.50
Share holders equity per share
835.58K438.24455.77432.310
Interest debt per share
46.92K25.4119.4940.240
Market cap
42.64B97218.32B97683.48B95357.68B0
Enterprise value
3016.31B94436.26B95091.09B94461.03B1732.28B
P/E ratio
0.0127.128.5435.410
Price to sales ratio
0.0112.5412.4113.050
POCF ratio
0.0595.43114.15283.730
PFCF ratio
0.06126.57147.321.9K0
P/B Ratio
04.774.614.740
PTB ratio
04.774.614.740
EV to sales
-0.4112.1812.0812.92-0.23
Enterprise value over EBITDA
-2.5269.0776.53105.89-2.12
EV to operating cash flow
-3.2192.7111.12281.06-1.84
EV to free cash flow
-4.5122.95143.411.88K-2.64
Earnings yield
19.90.010.010.010
Free cash flow yield
15.720.010.0100
Debt to equity
0.060.060.040.090.05
Debt to assets
0.040.040.030.070.04
Net debt to EBITDA
-2.56-2.03-2.09-1.01-2.12
Current ratio
3.83.773.813.353.9
Interest coverage
132.2886.0563.3331.7531.02
Income quality
1.111.14100
Dividend Yield
1.810000
Payout ratio
0.090000
Sales general and administrative to revenue
0.010.020.010.020.01
Research and developement to revenue
0.02-0.010.010.030.02
Intangibles to total assets
0.050.060.050.060.06
Capex to operating cash flow
-0.29-0.25-0.23-0.85-0.3
Capex to revenue
-0.04-0.03-0.02-0.04-0.04
Capex to depreciation
-2.98-2.05000
Stock based compensation to revenue
00000
Graham number
827.43K435.98434.34375.220
ROIC
0.040.040.040.030.03
Return on tangible assets
0.030.030.030.030.02
Graham Net
276.61K141.98146.53122.210
Working capital
11896.17B12279.19B12956.48B11679.2B12137.74B
Tangible asset value
19942.46B20569.21B21387.38B20118.31B20692.85B
Net current asset value
11111.1B11566.24B12249.53B11015.9B11508.35B
Invested capital
0.060.060.040.090.05
Average receivables
5002.9B5327.17B5886.22B6282.25B6198.1B
Average payables
1935.42B1981.89B2228.59B2272.16B1992.24B
Average inventory
6332.61B6834.28B7331.81B7522.03B7298.95B
Days sales outstanding
63.2464.0871.5277.7174.18
Days payables outstanding
40.5137.5847.6243.0836.78
Days of inventory on hand
136.75132.25147.8153.14139.14
Receivables turnover
1.421.41.261.161.21
Payables turnover
2.222.41.892.092.45
Inventory turnover
0.660.680.610.590.65
ROE
0.040.040.040.030.03
Capex per share
-11.52K-5.39-4.14-6.150

KLBF.JK Frequently Asked Questions

What is PT Kalbe Farma Tbk. stock symbol ?

PT Kalbe Farma Tbk. is a ID stock and trading under the symbol KLBF.JK

What is PT Kalbe Farma Tbk. stock quote today ?

PT Kalbe Farma Tbk. stock price is $1600 today.

Is PT Kalbe Farma Tbk. stock public?

Yes, PT Kalbe Farma Tbk. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap